Hyperion Therapeutics, Inc

Hyperion Therapeutics, Inc

Hyperion Therapeutics, Inc

Hyperion Therapeutics is a biopharmaceutical company focused on creating treatments for urea cycle disorders and other rare diseases.
Founded
2006
Raised
$115M
Follow us
Alexa global traffic share
Acquired by
Horizon Pharma plc
30 Mar 2015
$1,100,000,000
Latest funding Show all
$60,000,000
Venture capital (Series C) - 2009
Highland Capital Partners NEA Sofinnova Ventures +1
$15,000,000
Debt financing - 2007
Comerica Bank Life Sciences Partners

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Hyperion Therapeutics, Inc makes some noise.